Medicine
How Does Biotechnology Turn DNA into Medicine?
Quick fact
The first biotech drug, recombinant human insulin, was approved in 1982 and is produced by bacteria carrying the human insulin gene.
Why this is interesting
You've heard that DNA is the blueprint of life, but did you know scientists can turn that blueprint into life‑saving medicines?
Read the full explanation
Understanding How Does Biotechnology Turn DNA into Medicine?
Biotechnology turns DNA into medicine by treating living cells as microscopic factories. First, scientists identify the gene that codes for a useful protein—for example, the insulin protein needed by diabetics. They cut out that gene and insert it into a circular piece of DNA called a plasmid, which acts as a delivery vehicle. The plasmid is then placed into a host organism like bacteria or yeast. When the host reproduces, it replicates the plasmid and starts producing the human protein. The protein is then harvested, purified, and formulated into a medicine. It's like taking a recipe from a cookbook (DNA), copying just that page into a self‑contained recipe card (plasmid), and giving it to a restaurant kitchen (bacterial cell) to make the dish.
A deeper explanation
The process relies on recombinant DNA technology. Restriction enzymes cut DNA at specific sequences, and DNA ligase seals the gene into a plasmid vector. The plasmid contains a selectable marker (e.g., antibiotic resistance) so that only successfully modified host cells survive. The host cell's own machinery—ribosomes and RNA polymerase—reads the foreign gene and synthesizes the therapeutic protein. For more complex proteins that require human‑like modifications (e.g., antibodies), mammalian cells (like Chinese hamster ovary cells) are used instead of bacteria. Beyond proteins, DNA itself can be the medicine: gene therapy uses harmless viruses (viral vectors) to deliver a correct copy of a gene into a patient's cells, fixing genetic disorders. mRNA vaccines (like those for COVID‑19) go one step further—they deliver a synthetic messenger RNA that instructs the patient's own cells to produce a pathogen protein, triggering an immune response. The key insight is that DNA's information is portable: as long as the molecular machinery for reading it is present, a gene from one organism can be expressed in another, turning the universal language of life into targeted therapies.